Os Therapies Incorporated Stock Today
| OSTX Stock | 3.83 0.05 1.32% |
Performance7 of 100
| Odds Of DistressOver 69
|
OS Therapies is trading at 3.83 as of the 27th of December 2024; that is 1.32 percent increase since the beginning of the trading day. The stock's open price was 3.78. OS Therapies has more than 69 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 3rd of December 2023 and ending today, the 27th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of August 2024 | Category Healthcare | Classification Health Care |
OS Therapies is entity of United States. It is traded as Stock on NYSE MKT exchange. The company has 20.88 M outstanding shares of which 8.93 K shares are now shorted by private and institutional investors with about 0.01 trading days to cover. More on OS Therapies Incorporated
Moving against OSTX Stock
OSTX Stock Highlights
| President Founder | Paul MPH | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OS Therapies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand OS Therapies' financial leverage. It provides some insight into what part of OS Therapies' total assets is financed by creditors. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OS Therapies Incorporated (OSTX) is traded on NYSE MKT Exchange in USA. It is located in 15825 Shady Grove Road, Rockville, MD, United States, 20850 and employs 5 people. OS Therapies is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 74.14 M. OS Therapies conducts business under Biotechnology sector and is part of Health Care industry. The entity has 20.88 M outstanding shares of which 8.93 K shares are now shorted by private and institutional investors with about 0.01 trading days to cover.
OS Therapies generates negative cash flow from operations
Check OS Therapies Probability Of Bankruptcy
Ownership AllocationOS Therapies secures a total of 20.88 Million outstanding shares. OS Therapies shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check OSTX Ownership Details
OS Therapies Historical Income Statement
OSTX Stock Against Markets
OS Therapies Corporate Management
| Jack Doll | Chief Staff | Profile | |
| Robert Petit | Chief Officer | Profile | |
| Christopher Acevedo | Chief Officer | Profile | |
| Gerald Commissiong | Chief Officer | Profile |
Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.